Advanced search
1 file | 125.76 KB Add to list

Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class

Author
Organization
Keywords
REVERSE-TRANSCRIPTASE INHIBITORS, BR-77, bromine labelling, HPLC purification, [Br-77]TMC125-R165335 (etravirine), anti-HIV DAPY-NNRTI

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 125.76 KB

Citation

Please use this url to cite or link to this publication:

MLA
De Spiegeleer, Bart, et al. “Synthesis and HPLC-Purification of [Br-77]TMC125-R165335 (Etravirine), a New Anti-HIV Drug of the DAPY-NNRTI Class.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 49, no. 8, JOHN WILEY & SONS LTD, 2006, pp. 683–86, doi:10.1002/jlcr.1085.
APA
De Spiegeleer, B., Dumont, F., Peremans, K., Burvenich, C., Van Vooren, L., ROSIER, J., … Slegers, G. (2006). Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 49(8), 683–686. https://doi.org/10.1002/jlcr.1085
Chicago author-date
De Spiegeleer, Bart, Filip Dumont, Kathelijne Peremans, Christian Burvenich, Lieven Van Vooren, J ROSIER, L BAERT, P WIGERINCK, and Guido Slegers. 2006. “Synthesis and HPLC-Purification of [Br-77]TMC125-R165335 (Etravirine), a New Anti-HIV Drug of the DAPY-NNRTI Class.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 49 (8): 683–86. https://doi.org/10.1002/jlcr.1085.
Chicago author-date (all authors)
De Spiegeleer, Bart, Filip Dumont, Kathelijne Peremans, Christian Burvenich, Lieven Van Vooren, J ROSIER, L BAERT, P WIGERINCK, and Guido Slegers. 2006. “Synthesis and HPLC-Purification of [Br-77]TMC125-R165335 (Etravirine), a New Anti-HIV Drug of the DAPY-NNRTI Class.” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 49 (8): 683–686. doi:10.1002/jlcr.1085.
Vancouver
1.
De Spiegeleer B, Dumont F, Peremans K, Burvenich C, Van Vooren L, ROSIER J, et al. Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2006;49(8):683–6.
IEEE
[1]
B. De Spiegeleer et al., “Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class,” JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, vol. 49, no. 8, pp. 683–686, 2006.
@article{345335,
  author       = {{De Spiegeleer, Bart and Dumont, Filip and Peremans, Kathelijne and Burvenich, Christian and Van Vooren, Lieven and ROSIER, J and BAERT, L and WIGERINCK, P and Slegers, Guido}},
  issn         = {{0362-4803}},
  journal      = {{JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS}},
  keywords     = {{REVERSE-TRANSCRIPTASE INHIBITORS,BR-77,bromine labelling,HPLC purification,[Br-77]TMC125-R165335 (etravirine),anti-HIV DAPY-NNRTI}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{683--686}},
  publisher    = {{JOHN WILEY & SONS LTD}},
  title        = {{Synthesis and HPLC-purification of [Br-77]TMC125-R165335 (etravirine), a new anti-HIV drug of the DAPY-NNRTI class}},
  url          = {{http://doi.org/10.1002/jlcr.1085}},
  volume       = {{49}},
  year         = {{2006}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: